Ligand Pharmaceuticals Incorporated (LGNYZ)
OTCMKTS · Delayed Price · Currency is USD
0.0370
0.00 (0.00%)
At close: Jan 7, 2026
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of $3.66 billion as of February 12, 2026. Its market cap has increased by 65.16% in one year.
Market Cap
3.66B
Enterprise Value
3.45B
Revenue
251.23M
Ranking
n/a
PE Ratio
75.34
Stock Price
$0.04
Market Cap Chart
Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 76.19M to 3.66B, an increase of 4,703.80%. That is a compound annual growth rate of 13.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.68B | -1.08% |
| Dec 31, 2025 | 3.72B | 83.80% |
| Dec 31, 2024 | 2.02B | 62.59% |
| Dec 29, 2023 | 1.25B | 10.35% |
| Dec 30, 2022 | 1.13B | -56.28% |
| Dec 31, 2021 | 2.58B | 61.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 766.76M |
| Glass House Brands | 761.25M |
| Elite Pharmaceuticals | 473.68M |
| Nika Pharmaceuticals | 403.38M |
| Northwest Biotherapeutics | 399.44M |
| American Oncology Network | 377.98M |
| OpGen | 340.99M |
| CytoDyn | 311.51M |